Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
I don't usually buy into small biotechs w/o at least one product. But this company's novel technology, and 2 potentially huge drugs in late stage trials, warrant investment and waiting for the outcomes. So far, the end point results have been spectacular. However, we all know what can happen to late stage trials. That uncertainty is probably keeping the stock price subdued. The success so far in the Heplisav trials may result in an earlier filing with the FDA than the market expects. That could explode the stock and would be, I think, a better time to add to the position. I'm positive on this stock and have added shares; now it's wait time.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.